Fibroblast Activation Protein-Targeted Radiopharmaceutical Therapy Using ¹⁷⁷Lu-, ⁹⁰Y-, and ²²⁵Ac-Labeled 3BP-3940: First Experience in 21 Different Advanced Malignancies.

已取消 20 由 Layla 发布于 2026/6/15 18:54:16

DOI:10.2967/jnumed.125.271129
作者：Richard P. Baum, Tianzhi Zhao, Vivianne Jakobsson, Lukas Greifenstein, Aleksandr Eismant, Kriti Ghai, Aditi Mishra, Andre Klega, Christian Landvogt, Corinna Mueller, Daniel Benz-Zils, Ortwin Klein, Ba
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://jnm.snmjournals.org/content/67/6/910
管理员驳回:超时未应助，系统关闭。如求助信息不完整（标题、DOI、原文链接），可以补充后重新发布求助。

其它数据库

Abstract：Fibroblast activation protein (FAP) is an attractive target for molecular precision imaging and therapy, given its specific tumor expression across various cancer types. We report first-in-h

应助信息

2026-06-15

Book学术机器人

2026/6/15 18:54:17 未找到该文献，机器人已退出，请等待人工下载

2026/6/15 18:54:16 Book学术AI机器人收到请求，开始寻找文献

2026/6/15 18:54:16 已向机器人发送请求

2026-06-15

Layla 发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:ElsevierAdvances, opportunities, and challenges of hydrogen and oxygen production from seawater electrolysis: An electrocatalysis perspective

Fibroblast Activation Protein-Targeted Radiopharmaceutical Therapy Using 177Lu-, 90Y-, and 225Ac-Labeled 3BP-3940: First Experience in 21 Different Advanced Malignancies.

Fibroblast Activation Protein-Targeted Radiopharmaceutical Therapy Using ¹⁷⁷Lu-, ⁹⁰Y-, and ²²⁵Ac-Labeled 3BP-3940: First Experience in 21 Different Advanced Malignancies.